1-8 of 8
Maria Elisabeth Goebeler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results from a Phase I Dose Escalation Study of the Rapidly-Switchable Universal CAR-T Therapy UniCAR-T-CD123 in Relapsed/Refractory AML

Martin Wermke, Stephan Metzelder, Sabrina Kraus, Elisa Sala, Vladan Vucinic, Walter Fiedler, Katrin Wetzko, Jonas Schäfer, Maria-Elisabeth Goebeler, Jan Koedam, Kristin Franke, Matti Vänskä, Armin Ehninger, Marc Cartellieri, Gerhard Ehninger, Tapan Maniar
Journal: Blood
Blood (2023) 142 (Supplement 1): 3465.
https://doi.org/10.1182/blood-2023-177867
Published: 2023
Journal Articles

Phase 1 Dose Escalation Study of the Rapidly Switchable Universal CAR-T Therapy Unicar-T-CD123 in Relapsed/Refractory AML

Gerhard Ehninger, Sabrina Kraus, Elisa Sala, Stephan K Metzelder, Vladan Vucinic, Walter Fiedler, Maria-Elisabeth Goebeler, Jan Moritz Middeke, Malte von Bonin, Carla Kreissig, Jan Koedam, Marc Cartellieri, Armin Ehninger, Martin Wermke, Jonas A. Schäfer
Journal: Blood
Blood (2022) 140 (Supplement 1): 2367–2368.
https://doi.org/10.1182/blood-2022-168877
Published: 2022
Journal Articles

Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML

Martin Wermke, Sabrina Kraus, Armin Ehninger, Ralf C. Bargou, Maria-Elisabeth Goebeler, Jan Moritz Middeke, Carla Kreissig, Malte von Bonin, Jan Koedam, Michael Pehl, Martin Bornhäuser, Hermann Einsele, Gerhard Ehninger, Marc Cartellieri
Journal: Blood
Blood (2021) 137 (22): 3145–3148.
https://doi.org/10.1182/blood.2020009759
Published: 2021
Journal Articles

"Duration of Deep Molecular Response" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial

Susanne Saussele, MD, Johan Richter, MD PhD, Joelle Guilhot, PhD, Henrik Hjorth-Hansen, MD, Antonio Medina de Almeida, MD PhD, Jeroen J. W. M. Janssen, MD, Jiri Mayer, Prof, MD SCs, Perttu Koskenvesa, MD, Panayiotis Panayiotidis, MD PhD, Ulla Olsson-Strömberg, MD PhD, Juan Luis Steegmann, MD PhD, Hanne Vestergaard, MD, Hans Ehrencrona, MD PhD, Veli Kairisto, Kateřina Machová Poláková, PhD, Martin Müller, MD, Satu Mustjoki, MDPhD, Marc G. Berger, MD PhD, Philippe Rousselot, Martine Escoffre-Barbe, MD, Gabriel Etienne, MD PhD, Jolanta Dengler, MD, Françoise Rigal-Huguet, MD, Nikolas von Bubnoff, MD, Hana Klamova, MD, Edgar Faber, MD, François Guilhot, MD, Kourosh Lotfi, MD, Delphine Rea, MD, Tim H. Brümmendorf, MD, Gorgine de Greef, MD, Leif Stenke, MD, Franck Emmanuel Nicolini, MD PhD, Laurence Legros, MD PhD, Andreas Burchert, MD, Jaroslava Voglová, MD, Aude Charbonnier, MD, Emmanuel Gyan, MDPhD, Maria-Elisabeth Goebeler, MD, Peter E. Westerweel, MD, Andreas Hochhaus, MD, Markus Pfirrmann, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 313.
https://doi.org/10.1182/blood.V130.Suppl_1.313.313
Published: 2017
Journal Articles

Bispecific T-Cell Engager Antibody Construct Blinatumomab Shows Durable Response in a Long-Term Follow-up Analysis of 38 NHL Patients Treated in a Phase I Trial

Vera Dufner, Maria-Elisabeth Goebeler, Cyrus Sayheli, Ralf C. Bargou
Journal: Blood
Blood (2015) 126 (23): 3974.
https://doi.org/10.1182/blood.V126.23.3974.3974
Published: 2015
Journal Articles

Frequency of CTLA-4 Receptor Ligand (CD86, B7.2) -Positive Plasmacytoid Dendritic Cells Predicts Risk of Disease Recurrence after Tyrosine-Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Results from a Prospective Substudy of the Euroski Trial

Andreas Burchert, MD, Sabrina Inselmann, Susanne Saussele, Christian T. Dietz, PhD, Martin C. Müller, MD, Ekkehard Eigendorff, MD, Tim H. Brümmendorf, Prof MD, Cornelius Waller, MD, Jolanta Dengler, MD, Maria Elisabeth Goebeler, MD, Regina Herbst, MD, Gernot Freunek, MD, Stefan Hanzel, MD, Thomas Illmer, MD, Ying Wang, MD, Andreas Neubauer, MD, Thoralf Lange, MD, Andreas Hochhaus, MD, Finkernagel Florian, Cornelia A. Brendel, MD, Joelle Guilhot, PhD, Francois Xavier Mahon, MD PhD, Christin Schütz
Journal: Blood
Blood (2015) 126 (23): 599.
https://doi.org/10.1182/blood.V126.23.599.599
Published: 2015
Journal Articles

Cyclophosphamide, Adriamycin, Vincristine and Prednisone Plus Rituximab (CHOP-R) in Fludarabine (F) Refractory Chronic Lymphocytic Leukemia (CLL) or CLL with Autoimmune Cytopenia (AIC) or Richter's Transformation (RT): Final Analysis of a Phase II Study of the German CLL Study Group

Petra Jenke, Barbara Eichhorst, MD, Raymonde Busch, Nadine Anheier, Ulrich Duehrsen, MD, Jan Duerig, Martin H. Dreyling, PhD, Manuela Bergmann, MD, Maria Elisabeth Goebeler, Hans Juergen Hurtz, Martina Beate Stauch, Stephan Stilgenbauer, MD, Hartmut Doehner, Prof. Dr. med., Anna-Maria Fink, MD, Kirsten Fischer, MD, Clemens-Martin Wendtner, MD, Michael Hallek, MD
Journal: Blood
Blood (2011) 118 (21): 2860.
https://doi.org/10.1182/blood.V118.21.2860.2860
Published: 2011
Journal Articles

IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection

Stephan Hellmig, Steffen Vollenberg, Maria-Elisabeth Goebeler-Kolve, Wolfgang Fischbach, Jochen Hampe, Ulrich Robert Fölsch, Stefan Schreiber
Journal: Blood
Blood (2004) 104 (9): 2994–2995.
https://doi.org/10.1182/blood-2004-05-1792
Published: 2004